PTHS
$24.00+0.00 (+0.00%)
Market OpenAs of Mar 17, 1:46 PM UTC
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$24.00
Potential Upside
5%
Whystock Fair Value$25.20
Price
UndervaluedFair ValueOvervalued
Fundamentals
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 y...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$77.65M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-83.00%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.90